Aster DM Healthcare Share Price Today Live Updates, 28 Nov, 2024: Aster DM Healthcare on the radar

Go to Live Updates

Aster DM Healthcare Share Price Today Live Updates, 28 Nov, 2024: The Aster DM Healthcare share is in news and the counter closed trade on 27 Nov, 2024 at Rs 478.45. The shares touched an intraday high of Rs 483.85 in the last trading session while the intraday low was at Rs 441.55. The company’s market capitalization, as on 27 Nov, 2024, is at Rs 23899.2 crore. Aster DM Healthcare shares recorded a 52-week high of Rs 558.3 and a 52-week low of Rs 312.25. The trading volume on BSE was 218806 shares on 27 Nov, 2024.

Live Updates 09:30 (IST) 28 Nov 2024 Aster DM Healthcare Share Price Today Live Updates, 28 Nov, 2024: Key Support and Resistance Levels Aster DM Healthcare’s daily pivot level is set at Rs 479.98, with resistance levels at Rs 484.12 (R1), Rs 488.73 (R2), and Rs 492.87 (R3). Support levels are positioned at Rs 475.37 (S1), Rs 471.23 (S2), and Rs 466.62 (S3). Keep an eye on these levels as the trading day progresses, as they offer important insights into potential market movements. 09:16 (IST) 28 Nov 2024 Aster DM Healthcare Share Price Today Live Updates, 28 Nov, 2024: Aster DM Healthcare Stock Up by 0.19%; Currently Trading at Rs 479.35 Aster DM Healthcare stock is trading at Rs 479.35, reflecting a 0.19% increase. This translates to a net change of Rs 0.90 from the previous close, indicating a slight increase in the stock price. Investors should keep an eye on Aster DM Healthcare’s performance as the market reacts to ongoing developments. 08:55 (IST) 28 Nov 2024 Aster DM Healthcare Share Price Today Live Updates, 28 Nov, 2024: Aster DM Healthcare’s SMA and EMA Trends Aster DM Healthcare’s latest moving averages reveal key trends across various time frames. The 5-day Simple Moving Average (SMA) is at Rs 440.12, slightly above the 5-day Exponential Moving Average (EMA) of Rs 435.99. Over 10 days, the SMA is Rs 440.12, while the EMA is Rs 435.03. The 20-day SMA stands at Rs 430.74 compared to the EMA of Rs 433.66. For longer periods, the 50-day SMA is Rs 420.46, and the 100-day SMA is Rs 391.04, with the EMA at Rs 411.59. The 200-day SMA is Rs 402.98, reflecting broader trends and potential support levels for investors to watch. 08:30 (IST) 28 Nov 2024 Aster DM Healthcare Share Price Today Live Updates,  » Read More

Related Articles

Top 5 dividend yield mutual funds with highest returns in 5 years

Do you want a mutual fund scheme that gives you regular income along with investment? If yes, then dividend yield mutual funds can be the right choice for you. These funds invest in companies that give a part of their profits to investors in the form of dividends. That is, you get not only capital

After Goldman Sachs, Nuvama cuts target price for BSE. 3 big worries are…

The brokerage firm, Nuvama Institutional Equities, slashed the target price on BSE by almost 30% to Rs 5,160 from Rs 7,250. The cut in target price came after NSE shifted its index option expiry day to Monday from Thursday, a day ahead of Sensex’s index option expiry.  It also cut the net profit estimates by

Why Zee Entertainment promoters hiking stake is good news?

Zee Entertainment Enterprises (ZEEL) is back in the spotlight after its promoters increased their stake in the company. According to the brokerage, Nuvama, the company’s subscription revenue continues to rise steadily, while advertisement revenue is expected to recover in the coming quarters. The brokerage has maintained a ‘Buy’ rating for the stock. Let’s break it

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Top 5 dividend yield mutual funds with highest returns in 5 years

Do you want a mutual fund scheme that gives you regular income along with investment? If yes, then dividend yield mutual funds can be the right choice for you. These funds invest in companies that give a part of their profits to investors in the form of dividends. That is, you get not only capital

After Goldman Sachs, Nuvama cuts target price for BSE. 3 big worries are…

The brokerage firm, Nuvama Institutional Equities, slashed the target price on BSE by almost 30% to Rs 5,160 from Rs 7,250. The cut in target price came after NSE shifted its index option expiry day to Monday from Thursday, a day ahead of Sensex’s index option expiry.  It also cut the net profit estimates by

Why Zee Entertainment promoters hiking stake is good news?

Zee Entertainment Enterprises (ZEEL) is back in the spotlight after its promoters increased their stake in the company. According to the brokerage, Nuvama, the company’s subscription revenue continues to rise steadily, while advertisement revenue is expected to recover in the coming quarters. The brokerage has maintained a ‘Buy’ rating for the stock. Let’s break it

Nuvama’s top 3 Buy recommendations in falling market

The markets ended on a negative note with the the Nifty closing below 22,500 but that it’s not all doom and gloom, While the pain continues in the mid and small caps continue, there are select stocks with attractive valuations at the moment. Nuvama Institutional Equities has listed out three stocks that offer significant upside

Sustainability Meets Luxury: How biophilic design is shaping modern real estate

India’s real estate landscape is constantly evolving, and this transformation has accelerated in recent years. With growing interest in luxury living and shifting priorities post-pandemic, homebuyers are increasingly drawn to sustainable lifestyles, spacious designs, and premium amenities under one roof. Trust in new projects is rising significantly, thanks to stricter regulatory oversight by state RERA